葡萄糖限制保护癌细胞免受由皮里米丁限制和复制抑制诱导的亡
Minwoo Nam1,2, Wenxin Xia2,3, Abdul Hannan Mir1,2
1Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.
Nature metabolism
|November 26, 2024
概括
瘤中的低葡萄糖水平通过保护皮里米丁生物合成和抑制亡来保护癌细胞. 这种代谢适应可能会限制某些化疗药物的有效性,这强调了瘤微环境在癌症治疗中的重要性.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 分子生物学分子生物学
背景情况:
- 癌细胞呈现出快速增殖,导致瘤微环境中的营养限制条件.
- 不充分的瘤血管系统加剧了营养稀缺,迫使癌细胞在代谢上适应.
- 葡萄糖是癌细胞的主要营养素,其水平在瘤中经常降低.
研究的目的:
- 研究葡萄糖限制对癌细胞代谢途径的影响.
- 确定低葡萄糖影响癌细胞存活率和对化疗反应的机制.
- 了解瘤营养环境如何影响治疗疗效.
主要方法:
- 基于CRISPR的基因选被用来识别受葡萄糖限制影响的代谢途径.
- 癌细胞在不同的葡萄糖度下培养,包括瘤相关的低葡萄糖水平.
- 分析了细胞存活,金胺生物合成和亡的机制.
主要成果:
- 低度的葡萄糖保护癌细胞免受新皮里米丁生物合成的抑制,这是常见的化疗点.
- 确定了两个关键机制: 1) 限制了尿素-5-二酸盐-葡萄糖合成,保留了胺核酸,并延迟了复制分叉停滞; 2) 通过抑制BAK激活和细胞染色体c释放,抑制了细胞亡.
- 这些保护作用在不同类型的癌症中被广泛观察到.
结论:
- 与瘤相关的低葡萄糖水平可以通过调节癌细胞代谢和生存途径来赋予某些化疗的耐药性.
- 这些发现突出了瘤微环境的关键作用,特别是营养的可用性,在确定癌症治疗结果.
- 考虑瘤的代谢状态对于优化癌症治疗策略至关重要.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K